超重和肥胖患者在原药和仿制药之间的选择问题

Q3 Medicine

Obesity and Metabolism Pub Date : 2013-10-30 DOI:10.14341/2071-8713-3861

M. Maksimov

{"title":"超重和肥胖患者在原药和仿制药之间的选择问题","authors":"M. Maksimov","doi":"10.14341/2071-8713-3861","DOIUrl":null,"url":null,"abstract":"This review article discusses the similarities and differences in the research, production and use in clinical practice, original and generic drugs. Reproduced drugs (generics) present on the Russian pharmaceutical market that have the bioequivalence data are not always equal in therapeutic equivalence of the original drug. The article presents evidence base of efficacy and safety of the original drug Xenical in the complex treatment of patients with overweight and obesity.","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"10 1","pages":"19-26"},"PeriodicalIF":0.0000,"publicationDate":"2013-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The problem of choosing between the original and of generic drugs in patients with overweight and obesity\",\"authors\":\"M. Maksimov\",\"doi\":\"10.14341/2071-8713-3861\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This review article discusses the similarities and differences in the research, production and use in clinical practice, original and generic drugs. Reproduced drugs (generics) present on the Russian pharmaceutical market that have the bioequivalence data are not always equal in therapeutic equivalence of the original drug. The article presents evidence base of efficacy and safety of the original drug Xenical in the complex treatment of patients with overweight and obesity.\",\"PeriodicalId\":37832,\"journal\":{\"name\":\"Obesity and Metabolism\",\"volume\":\"10 1\",\"pages\":\"19-26\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity and Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14341/2071-8713-3861\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/2071-8713-3861","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文就原研药和仿制药的研究、生产和临床应用等方面的异同进行了综述。俄罗斯医药市场上具有生物等效性数据的仿制药(仿制药)在治疗等效性方面并不总是与原药相同。本文介绍了原药赛尼可在超重和肥胖患者综合治疗中的有效性和安全性的证据基础。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The problem of choosing between the original and of generic drugs in patients with overweight and obesity

This review article discusses the similarities and differences in the research, production and use in clinical practice, original and generic drugs. Reproduced drugs (generics) present on the Russian pharmaceutical market that have the bioequivalence data are not always equal in therapeutic equivalence of the original drug. The article presents evidence base of efficacy and safety of the original drug Xenical in the complex treatment of patients with overweight and obesity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Obesity and Metabolism Medicine-Internal Medicine

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Journal "Obesity and Metabolism" is a multidisciplinary forum for clinical and applied research in the field of biochemistry, physiology, pathophysiology, genetics, nutrition, as well as molecular, metabolic, psychological and epidemiological aspects of obesity and metabolism. The main subject "Metabolism" reviewed in the journal, includes fat, carbohydrate, protein, bone, fluid and electrolyte and other types of metabolism in the spectrum of pathology of the endocrine system. The priority direction of Journal "Obesity and Metabolism" is publishing modern high-quality original research on the effectiveness of new and existing treatments in any aspect of metabolic and endocrine diseases. Pre-clinical pharmacology, pharmacokinetics studies, meta-analyzes, addressed to drug safety and tolerance are also welcome for publication in the journal "Obesity and metabolism." Journal "Obesity and Metabolism" announces review articles that are balanced, clear and offer the reader a modern and critical analysis of the literature on the subject of the magazine. Case reports, and lecture materials are also published for highlighting for practitioners new approaches to diagnosis and treatment of patients with metabolic disorders and obesity.